{"entity":{"id":"nct05909332","kind":"trial","name":"Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)","aka":["BCTOP-T-A03"],"tldr":"A phase 3 trial in triple-negative breast cancer, run by Fudan University, now recruiting.","summary":"Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) is a phase 3, randomised interventional study registered as NCT05909332 by Fudan University, with a registry enrolment figure of 764 participants, started 2023-06-20 and due to reach its primary completion in 2029-05-30. Interventions recorded: Antivascular therapy; Chemotherapy. Conditions listed: Breast Cancer; Triple Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"* Histological results recorded as TNBC (negative HER2, ER, and PgR status) and BLIS subtype according to the classification of FUSCC;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05909332","url":"https://clinicaltrials.gov/study/NCT05909332"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05909332","phase":"3","setting":"A Randomized, Open-label Phase III Clinical Trial Comparing Antivascular Therapy Combined With Standard Chemotherapy and Standard Chemotherapy in Adjuvant Therapy for Patients With Triple-Negative Breast Cancer, Basal-like Immunosuppressed Subtype (BCTOP-T-A03)","sponsor":"Fudan University","participation":[{"nct":"NCT05909332","source":"https://clinicaltrials.gov/study/NCT05909332","fetchedAt":"2026-10-07T16:54:00.715Z","studySha256":"4d7d69ab264a6fa2f2ce7870d43808f44a83871decea47d50e7218a1812412dd","overallStatus":"RECRUITING","lastUpdatePosted":"2026-01-21","leadSponsor":"Fudan University","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"70 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":764,"enrolmentType":"ESTIMATED","siteCount":15,"recruitingSiteCount":15,"countries":["China"]}],"started":"2023-06-20","startedType":"actual","enrolled":764,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05909332/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}